# Chegg timeline

entity: /record/chegg.md  
id: ent_chegg  


## undated

- undated | fiscal_year_end | 12-31 | valid | [clm_1FF183660E48](/claim/clm_1FF183660E48.md)
- undated | sic_industry | Services-Educational Services (8200) | valid | [clm_41F906D36160](/claim/clm_41F906D36160.md)
- undated | state_of_incorporation | DE | valid | [clm_48ED8C7713E2](/claim/clm_48ED8C7713E2.md)
- undated | cik | 0001364954 | valid | [clm_526DA9101FA3](/claim/clm_526DA9101FA3.md)
- undated | ticker | CHGG | valid | [clm_5A5849D4DAA1](/claim/clm_5A5849D4DAA1.md)
- undated | listed_on | NYSE | valid | [clm_61743D976CE0](/claim/clm_61743D976CE0.md)
- undated | website | http://www.chegg.com/ | unverified | [clm_06D28A7F220A](/claim/clm_06D28A7F220A.md)
- undated | legal_form | Delaware corporation | unverified | [clm_322DE2115019](/claim/clm_322DE2115019.md)
- undated | headquarters | Santa Clara | unverified | [clm_55F8D7967579](/claim/clm_55F8D7967579.md)

## 2006

- 2006-05-22 | registrant_name | CHEGG, INC | valid | [clm_73CA20C8F544](/claim/clm_73CA20C8F544.md)

## 2008

- 2008-12-07 | x_username | Chegg | unverified | [clm_A4FB46D13E19](/claim/clm_A4FB46D13E19.md)

## 2010

- 2010-02-01 to 2024-06-01 | ceo | Dan Rosensweig | superseded | [clm_5B0D3DCE73F1](/claim/clm_5B0D3DCE73F1.md)

## 2011

- 2011-12-31 to 2012-12-31 | cash_and_equivalents | 34,607,000 United States dollar | superseded | [clm_419C9CD99BE1](/claim/clm_419C9CD99BE1.md)
- 2011-12-31 to 2012-12-31 | total_equity | -51,894,000 United States dollar | superseded | [clm_DD9C2E59ECF0](/claim/clm_DD9C2E59ECF0.md)

## 2012

- 2012-12-31 to 2013-12-31 | total_equity | -86,127,000 United States dollar | superseded | [clm_477851B7C1DF](/claim/clm_477851B7C1DF.md)
- 2012-12-31 to 2013-12-31 | net_income | -49,043,000 United States dollar | superseded | [clm_478B9E548C7E](/claim/clm_478B9E548C7E.md)
- 2012-12-31 to 2013-12-31 | operating_income | -45,255,000 United States dollar | superseded | [clm_4B0FA1D400C5](/claim/clm_4B0FA1D400C5.md)
- 2012-12-31 to 2013-12-31 | research_and_development | 39,315,000 United States dollar | superseded | [clm_C63FCB30141A](/claim/clm_C63FCB30141A.md)
- 2012-12-31 to 2013-03-31 | cash_and_equivalents | 21,030,000 United States dollar | superseded | [clm_E9A101F53856](/claim/clm_E9A101F53856.md)
- 2012-12-31 to 2013-12-31 | revenue | 213,334,000 United States dollar | superseded | [clm_F5382745481E](/claim/clm_F5382745481E.md)

## 2013

- 2013-03-31 to 2013-06-30 | quarterly_net_income | -17,825,000 United States dollar | superseded | [clm_47BDBC55B971](/claim/clm_47BDBC55B971.md)
- 2013-03-31 to 2013-06-30 | cash_and_equivalents | 30,294,000 United States dollar | superseded | [clm_5B224B300118](/claim/clm_5B224B300118.md)
- 2013-03-31 to 2013-06-30 | quarterly_research_and_development | 9,553,000 United States dollar | superseded | [clm_6977A22D4113](/claim/clm_6977A22D4113.md)
- 2013-03-31 to 2013-06-30 | quarterly_operating_income | -16,170,000 United States dollar | superseded | [clm_D2AE149C9D3D](/claim/clm_D2AE149C9D3D.md)
- 2013-03-31 to 2013-06-30 | quarterly_revenue | 61,015,000 United States dollar | superseded | [clm_E984FA4849F4](/claim/clm_E984FA4849F4.md)
- 2013-06-30 to 2013-09-30 | quarterly_revenue | 55,857,000 United States dollar | superseded | [clm_119C6488B3CE](/claim/clm_119C6488B3CE.md)
- 2013-06-30 to 2013-09-30 | cash_and_equivalents | 21,639,000 United States dollar | superseded | [clm_335DD181DA4E](/claim/clm_335DD181DA4E.md)
- 2013-06-30 to 2013-09-30 | quarterly_net_income | -3,353,000 United States dollar | superseded | [clm_CB5BFA80E846](/claim/clm_CB5BFA80E846.md)
- 2013-06-30 to 2013-09-30 | quarterly_operating_income | -1,467,000 United States dollar | superseded | [clm_E64E1E432B15](/claim/clm_E64E1E432B15.md)
- 2013-06-30 to 2013-09-30 | quarterly_research_and_development | 9,799,000 United States dollar | superseded | [clm_F3B06B9C2C48](/claim/clm_F3B06B9C2C48.md)
- 2013-09-30 to 2014-03-31 | quarterly_operating_income | -24,904,000 United States dollar | superseded | [clm_0CAAE807653C](/claim/clm_0CAAE807653C.md)
- 2013-09-30 to 2014-03-31 | quarterly_revenue | 61,587,000 United States dollar | superseded | [clm_B9942F13BA96](/claim/clm_B9942F13BA96.md)
- 2013-09-30 to 2013-12-31 | cash_and_equivalents | 15,927,000 United States dollar | superseded | [clm_C665C108D9A0](/claim/clm_C665C108D9A0.md)
- 2013-09-30 to 2014-03-31 | quarterly_research_and_development | 9,999,000 United States dollar | superseded | [clm_F552A29FB02D](/claim/clm_F552A29FB02D.md)
- 2013-09-30 to 2014-03-31 | quarterly_net_income | -29,255,000 United States dollar | superseded | [clm_FD632E3A5F97](/claim/clm_FD632E3A5F97.md)
- 2013-12-31 to 2014-12-31 | net_income | -55,850,000 United States dollar | superseded | [clm_186F89CBFCCD](/claim/clm_186F89CBFCCD.md)
- 2013-12-31 to 2014-12-31 | operating_income | -51,031,000 United States dollar | superseded | [clm_220D5AAD3CE7](/claim/clm_220D5AAD3CE7.md)
- 2013-12-31 to 2014-03-31 | cash_and_equivalents | 76,864,000 United States dollar | superseded | [clm_4AFD1BAFC198](/claim/clm_4AFD1BAFC198.md)
- 2013-12-31 to 2014-03-31 | total_assets | 327,371,000 United States dollar | superseded | [clm_9AD74A7ED24A](/claim/clm_9AD74A7ED24A.md)
- 2013-12-31 to 2014-12-31 | research_and_development | 41,944,000 United States dollar | superseded | [clm_A9E946EB2DFE](/claim/clm_A9E946EB2DFE.md)
- 2013-12-31 to 2014-03-31 | total_equity | 274,240,000 United States dollar | superseded | [clm_B62448D0CD12](/claim/clm_B62448D0CD12.md)
- 2013-12-31 to 2014-12-31 | revenue | 255,575,000 United States dollar | superseded | [clm_E8458532C2A0](/claim/clm_E8458532C2A0.md)

## 2014

- 2014-03-31 to 2014-06-30 | quarterly_net_income | -25,759,000 United States dollar | superseded | [clm_08EF83C475FD](/claim/clm_08EF83C475FD.md)
- 2014-03-31 to 2014-06-30 | cash_and_equivalents | 39,440,000 United States dollar | superseded | [clm_174BB6C88703](/claim/clm_174BB6C88703.md)
- 2014-03-31 to 2014-06-30 | quarterly_operating_income | -25,601,000 United States dollar | superseded | [clm_2D09347011F0](/claim/clm_2D09347011F0.md)
- 2014-03-31 to 2014-06-30 | total_equity | 251,928,000 United States dollar | superseded | [clm_3E181BDA234A](/claim/clm_3E181BDA234A.md)
- 2014-03-31 to 2014-06-30 | quarterly_revenue | 74,393,000 United States dollar | superseded | [clm_779B88AA8772](/claim/clm_779B88AA8772.md)
- 2014-03-31 to 2014-06-30 | total_assets | 332,765,000 United States dollar | superseded | [clm_D5175C915B38](/claim/clm_D5175C915B38.md)
- 2014-03-31 to 2014-06-30 | quarterly_research_and_development | 11,320,000 United States dollar | superseded | [clm_DE4FD9186201](/claim/clm_DE4FD9186201.md)
- 2014-04-30 to 2014-07-31 | shares_outstanding | 83,064,882 shares | superseded | [clm_1AD2A832C3A8](/claim/clm_1AD2A832C3A8.md)
- 2014-06-30 to 2014-09-30 | quarterly_net_income | -8,246,000 United States dollar | superseded | [clm_15C1CDA00498](/claim/clm_15C1CDA00498.md)
- 2014-06-30 to 2014-09-30 | quarterly_operating_income | -9,642,000 United States dollar | superseded | [clm_371747C3D4C2](/claim/clm_371747C3D4C2.md)
- 2014-06-30 to 2014-09-30 | cash_and_equivalents | 30,783,000 United States dollar | superseded | [clm_56D3F11EFA64](/claim/clm_56D3F11EFA64.md)
- 2014-06-30 to 2014-09-30 | total_assets | 314,522,000 United States dollar | superseded | [clm_65BA7A80549B](/claim/clm_65BA7A80549B.md)
- 2014-06-30 to 2014-09-30 | quarterly_research_and_development | 12,189,000 United States dollar | superseded | [clm_6FD8E6F2B7B7](/claim/clm_6FD8E6F2B7B7.md)
- 2014-06-30 to 2014-09-30 | quarterly_revenue | 64,492,000 United States dollar | superseded | [clm_B512BD779341](/claim/clm_B512BD779341.md)
- 2014-06-30 to 2014-09-30 | total_equity | 255,356,000 United States dollar | superseded | [clm_F5E2A527FCAD](/claim/clm_F5E2A527FCAD.md)
- 2014-07-31 to 2014-10-31 | shares_outstanding | 83,687,485 shares | superseded | [clm_4405F5C9C8A4](/claim/clm_4405F5C9C8A4.md)
- 2014-09-30 to 2014-12-31 | total_equity | 234,730,000 United States dollar | superseded | [clm_308C7E35BC3B](/claim/clm_308C7E35BC3B.md)
- 2014-09-30 to 2015-03-31 | quarterly_revenue | 81,532,000 United States dollar | superseded | [clm_5E0E89843998](/claim/clm_5E0E89843998.md)
- 2014-09-30 to 2015-03-31 | quarterly_research_and_development | 13,490,000 United States dollar | superseded | [clm_6B344C57D790](/claim/clm_6B344C57D790.md)
- 2014-09-30 to 2015-03-31 | quarterly_operating_income | -32,634,000 United States dollar | superseded | [clm_8E9B49185F39](/claim/clm_8E9B49185F39.md)
- 2014-09-30 to 2014-12-31 | cash_and_equivalents | 53,186,000 United States dollar | superseded | [clm_9FF5A022348A](/claim/clm_9FF5A022348A.md)
- 2014-09-30 to 2015-03-31 | quarterly_net_income | -32,441,000 United States dollar | superseded | [clm_B8E8F714771C](/claim/clm_B8E8F714771C.md)
- 2014-09-30 to 2014-12-31 | total_assets | 348,133,000 United States dollar | superseded | [clm_E5C8EF925C58](/claim/clm_E5C8EF925C58.md)
- 2014-10-31 to 2015-02-27 | shares_outstanding | 83,849,487 shares | superseded | [clm_670C48016191](/claim/clm_670C48016191.md)
- 2014-12-31 to 2015-03-31 | total_equity | 247,043,000 United States dollar | superseded | [clm_661C74AF5E2F](/claim/clm_661C74AF5E2F.md)
- 2014-12-31 to 2015-12-31 | net_income | -64,758,000 United States dollar | superseded | [clm_7337D6653C4E](/claim/clm_7337D6653C4E.md)
- 2014-12-31 to 2015-03-31 | cash_and_equivalents | 56,117,000 United States dollar | superseded | [clm_963DD61F2843](/claim/clm_963DD61F2843.md)
- 2014-12-31 to 2015-12-31 | revenue | 304,834,000 United States dollar | superseded | [clm_B1D50EADB91F](/claim/clm_B1D50EADB91F.md)
- 2014-12-31 to 2015-03-31 | total_assets | 318,127,000 United States dollar | superseded | [clm_CEB7F67F0790](/claim/clm_CEB7F67F0790.md)
- 2014-12-31 to 2015-12-31 | operating_income | -65,134,000 United States dollar | superseded | [clm_E612C61EF55B](/claim/clm_E612C61EF55B.md)
- 2014-12-31 to 2015-12-31 | research_and_development | 49,386,000 United States dollar | superseded | [clm_F67DEB0E100F](/claim/clm_F67DEB0E100F.md)

## 2015

- 2015-02-27 to 2015-04-30 | shares_outstanding | 84,501,198 shares | superseded | [clm_D8874769D31F](/claim/clm_D8874769D31F.md)
- 2015-03-31 to 2015-06-30 | total_assets | 309,728,000 United States dollar | superseded | [clm_7A5536382576](/claim/clm_7A5536382576.md)
- 2015-03-31 to 2015-06-30 | cash_and_equivalents | 50,028,000 United States dollar | superseded | [clm_951F7F28BCA2](/claim/clm_951F7F28BCA2.md)
- 2015-03-31 to 2015-06-30 | quarterly_research_and_development | 16,144,000 United States dollar | superseded | [clm_A3928EFDC4AC](/claim/clm_A3928EFDC4AC.md)
- 2015-03-31 to 2015-06-30 | quarterly_revenue | 84,872,000 United States dollar | superseded | [clm_A50606A7EA93](/claim/clm_A50606A7EA93.md)
- 2015-03-31 to 2015-06-30 | quarterly_operating_income | -28,263,000 United States dollar | superseded | [clm_D974952B1718](/claim/clm_D974952B1718.md)
- 2015-03-31 to 2015-06-30 | quarterly_net_income | -28,542,000 United States dollar | superseded | [clm_EBF4DFA20C77](/claim/clm_EBF4DFA20C77.md)
- 2015-03-31 to 2015-06-30 | total_equity | 235,441,000 United States dollar | superseded | [clm_FEF508383DDF](/claim/clm_FEF508383DDF.md)
- 2015-04-30 to 2015-07-31 | shares_outstanding | 86,049,734 shares | superseded | [clm_E11103205806](/claim/clm_E11103205806.md)
- 2015-06-30 to 2015-09-30 | quarterly_net_income | -10,131,000 United States dollar | superseded | [clm_0A0DC912F4E4](/claim/clm_0A0DC912F4E4.md)
- 2015-06-30 to 2015-09-30 | quarterly_revenue | 67,061,000 United States dollar | superseded | [clm_41B306C4C4E4](/claim/clm_41B306C4C4E4.md)
- 2015-06-30 to 2015-09-30 | quarterly_research_and_development | 13,268,000 United States dollar | superseded | [clm_5AF3EADBCC02](/claim/clm_5AF3EADBCC02.md)
- 2015-06-30 to 2015-09-30 | quarterly_operating_income | -9,697,000 United States dollar | superseded | [clm_8C54C503DF86](/claim/clm_8C54C503DF86.md)
- 2015-06-30 to 2015-09-30 | total_equity | 235,345,000 United States dollar | superseded | [clm_CB0378E16EF2](/claim/clm_CB0378E16EF2.md)
- 2015-06-30 to 2015-09-30 | total_assets | 287,564,000 United States dollar | superseded | [clm_CF15410A33F9](/claim/clm_CF15410A33F9.md)
- 2015-06-30 to 2015-09-30 | cash_and_equivalents | 35,087,000 United States dollar | superseded | [clm_FC1C3ACA9F30](/claim/clm_FC1C3ACA9F30.md)
- 2015-07-31 to 2015-10-31 | shares_outstanding | 87,655,772 shares | superseded | [clm_8E1E424E2F5B](/claim/clm_8E1E424E2F5B.md)
- 2015-09-30 to 2016-03-31 | quarterly_net_income | -24,167,000 United States dollar | superseded | [clm_1C8B4DEF9D0D](/claim/clm_1C8B4DEF9D0D.md)
- 2015-09-30 to 2016-03-31 | quarterly_revenue | 81,286,000 United States dollar | superseded | [clm_1CC27FB4E71C](/claim/clm_1CC27FB4E71C.md)
- 2015-09-30 to 2016-03-31 | quarterly_research_and_development | 15,664,000 United States dollar | superseded | [clm_3F3E99E00A9F](/claim/clm_3F3E99E00A9F.md)
- 2015-09-30 to 2015-12-31 | total_equity | 220,059,000 United States dollar | superseded | [clm_72B96FE370B6](/claim/clm_72B96FE370B6.md)
- 2015-09-30 to 2016-03-31 | quarterly_operating_income | -23,802,000 United States dollar | superseded | [clm_907147A2D2C9](/claim/clm_907147A2D2C9.md)
- 2015-09-30 to 2015-12-31 | cash_and_equivalents | 80,941,000 United States dollar | superseded | [clm_9F1075333B36](/claim/clm_9F1075333B36.md)
- 2015-09-30 to 2015-12-31 | total_assets | 322,057,000 United States dollar | superseded | [clm_BF092D263120](/claim/clm_BF092D263120.md)
- 2015-10-31 to 2015-11-30 | shares_outstanding | 87,883,862 shares | superseded | [clm_4EDA875DD072](/claim/clm_4EDA875DD072.md)
- 2015-11-30 to 2016-02-29 | shares_outstanding | 88,085,295 shares | superseded | [clm_4EA20E4B2182](/claim/clm_4EA20E4B2182.md)
- 2015-12-31 to 2016-12-31 | net_income | -59,210,000 United States dollar | superseded | [clm_1388185DC503](/claim/clm_1388185DC503.md)
- 2015-12-31 to 2016-12-31 | research_and_development | 59,391,000 United States dollar | superseded | [clm_7DB787783332](/claim/clm_7DB787783332.md)
- 2015-12-31 to 2016-12-31 | operating_income | -57,700,000 United States dollar | superseded | [clm_9F7D9D27D073](/claim/clm_9F7D9D27D073.md)
- 2015-12-31 to 2016-03-31 | total_equity | 231,075,000 United States dollar | superseded | [clm_D850DB864EC9](/claim/clm_D850DB864EC9.md)
- 2015-12-31 to 2016-12-31 | revenue | 301,373,000 United States dollar | superseded | [clm_E75155B8D0A5](/claim/clm_E75155B8D0A5.md)
- 2015-12-31 to 2016-03-31 | cash_and_equivalents | 67,029,000 United States dollar | superseded | [clm_F80E429DB964](/claim/clm_F80E429DB964.md)
- 2015-12-31 to 2016-03-31 | total_assets | 291,356,000 United States dollar | superseded | [clm_FE1068CE4E91](/claim/clm_FE1068CE4E91.md)

## 2016

- 2016-02-29 to 2016-04-29 | shares_outstanding | 89,956,930 shares | superseded | [clm_A5E6C9A24529](/claim/clm_A5E6C9A24529.md)
- 2016-03-31 to 2016-06-30 | quarterly_revenue | 66,654,000 United States dollar | superseded | [clm_2AB48C63EDCD](/claim/clm_2AB48C63EDCD.md)
- 2016-03-31 to 2016-06-30 | quarterly_research_and_development | 16,958,000 United States dollar | superseded | [clm_49B64083D0C7](/claim/clm_49B64083D0C7.md)
- 2016-03-31 to 2016-06-30 | total_assets | 274,716,000 United States dollar | superseded | [clm_981F3121C73C](/claim/clm_981F3121C73C.md)
- 2016-03-31 to 2016-06-30 | quarterly_operating_income | -15,290,000 United States dollar | superseded | [clm_A4CE755DEF41](/claim/clm_A4CE755DEF41.md)
- 2016-03-31 to 2016-06-30 | quarterly_net_income | -15,685,000 United States dollar | superseded | [clm_CB006A648F82](/claim/clm_CB006A648F82.md)
- 2016-03-31 to 2016-06-30 | total_equity | 220,397,000 United States dollar | superseded | [clm_D06AAF4522A6](/claim/clm_D06AAF4522A6.md)
- 2016-03-31 to 2016-06-30 | cash_and_equivalents | 41,504,000 United States dollar | superseded | [clm_D6A0932873BE](/claim/clm_D6A0932873BE.md)
- 2016-04-29 to 2016-07-29 | shares_outstanding | 90,124,729 shares | superseded | [clm_A4D5E9DD2213](/claim/clm_A4D5E9DD2213.md)
- 2016-06-30 to 2016-09-30 | quarterly_net_income | -9,008,000 United States dollar | superseded | [clm_085BE389D4A3](/claim/clm_085BE389D4A3.md)
- 2016-06-30 to 2016-09-30 | total_equity | 221,733,000 United States dollar | superseded | [clm_30BDA0371BED](/claim/clm_30BDA0371BED.md)
- 2016-06-30 to 2016-09-30 | cash_and_equivalents | 49,679,000 United States dollar | superseded | [clm_58D782C005E4](/claim/clm_58D782C005E4.md)
- 2016-06-30 to 2016-09-30 | quarterly_operating_income | -8,375,000 United States dollar | superseded | [clm_5CA66B1A75AF](/claim/clm_5CA66B1A75AF.md)
- 2016-06-30 to 2016-09-30 | quarterly_revenue | 53,036,000 United States dollar | superseded | [clm_70F467B726FD](/claim/clm_70F467B726FD.md)
- 2016-06-30 to 2016-09-30 | quarterly_research_and_development | 16,033,000 United States dollar | superseded | [clm_A6C082FB8A5B](/claim/clm_A6C082FB8A5B.md)
- 2016-06-30 to 2016-09-30 | total_assets | 292,888,000 United States dollar | superseded | [clm_FAA1E759706C](/claim/clm_FAA1E759706C.md)
- 2016-07-29 to 2016-10-31 | shares_outstanding | 91,028,255 shares | superseded | [clm_6D92F1383FA4](/claim/clm_6D92F1383FA4.md)
- 2016-09-30 to 2017-03-31 | quarterly_net_income | -16,063,000 United States dollar | superseded | [clm_167F250BB15F](/claim/clm_167F250BB15F.md)
- 2016-09-30 to 2017-03-31 | quarterly_operating_income | -15,331,000 United States dollar | superseded | [clm_495D825AAA47](/claim/clm_495D825AAA47.md)
- 2016-09-30 to 2016-12-31 | total_equity | 215,103,000 United States dollar | superseded | [clm_6343E98D2279](/claim/clm_6343E98D2279.md)
- 2016-09-30 to 2017-03-31 | quarterly_revenue | 71,343,000 United States dollar | superseded | [clm_6AFD85A94B46](/claim/clm_6AFD85A94B46.md)
- 2016-09-30 to 2017-03-31 | quarterly_research_and_development | 16,241,000 United States dollar | superseded | [clm_97CD87FB3615](/claim/clm_97CD87FB3615.md)
- 2016-09-30 to 2016-12-31 | cash_and_equivalents | 90,213,000 United States dollar | superseded | [clm_9963D8E360A1](/claim/clm_9963D8E360A1.md)
- 2016-09-30 to 2016-12-31 | total_assets | 316,208,000 United States dollar | superseded | [clm_D3A3B0288AB5](/claim/clm_D3A3B0288AB5.md)
- 2016-10-31 to 2017-01-31 | shares_outstanding | 91,347,606 shares | superseded | [clm_3896BD365494](/claim/clm_3896BD365494.md)
- 2016-12-31 to 2017-03-31 | total_assets | 290,652,000 United States dollar | superseded | [clm_0AD9A920F969](/claim/clm_0AD9A920F969.md)
- 2016-12-31 to 2017-12-31 | net_income | -42,245,000 United States dollar | superseded | [clm_207BB41212D8](/claim/clm_207BB41212D8.md)
- 2016-12-31 to 2017-03-31 | cash_and_equivalents | 77,329,000 United States dollar | superseded | [clm_6968FA1C00DA](/claim/clm_6968FA1C00DA.md)
- 2016-12-31 to 2017-12-31 | research_and_development | 66,331,000 United States dollar | superseded | [clm_85E94AE2BF51](/claim/clm_85E94AE2BF51.md)
- 2016-12-31 to 2017-12-31 | operating_income | -40,070,000 United States dollar | superseded | [clm_9FCF14291318](/claim/clm_9FCF14291318.md)
- 2016-12-31 to 2017-03-31 | total_equity | 221,939,000 United States dollar | superseded | [clm_DE63782D3341](/claim/clm_DE63782D3341.md)
- 2016-12-31 to 2017-12-31 | revenue | 254,090,000 United States dollar | superseded | [clm_E2DAA073D9BE](/claim/clm_E2DAA073D9BE.md)

## 2017

- 2017-01-31 to 2017-04-28 | shares_outstanding | 91,830,713 shares | superseded | [clm_E670D6E4C731](/claim/clm_E670D6E4C731.md)
- 2017-03-31 to 2017-06-30 | quarterly_net_income | -6,401,000 United States dollar | superseded | [clm_00375A11A27E](/claim/clm_00375A11A27E.md)
- 2017-03-31 to 2017-06-30 | total_equity | 214,062,000 United States dollar | superseded | [clm_3302E5299C0F](/claim/clm_3302E5299C0F.md)
- 2017-03-31 to 2017-06-30 | quarterly_research_and_development | 19,302,000 United States dollar | superseded | [clm_408340DBC34C](/claim/clm_408340DBC34C.md)
- 2017-03-31 to 2017-06-30 | cash_and_equivalents | 70,294,000 United States dollar | superseded | [clm_42E3B36F414D](/claim/clm_42E3B36F414D.md)
- 2017-03-31 to 2017-06-30 | quarterly_operating_income | -5,536,000 United States dollar | superseded | [clm_55E3ED343AD5](/claim/clm_55E3ED343AD5.md)
- 2017-03-31 to 2017-06-30 | quarterly_revenue | 62,602,000 United States dollar | superseded | [clm_A1C00FA25D0E](/claim/clm_A1C00FA25D0E.md)
- 2017-03-31 to 2017-06-30 | total_assets | 280,976,000 United States dollar | superseded | [clm_CE119066EFD7](/claim/clm_CE119066EFD7.md)
- 2017-04-28 to 2017-07-27 | shares_outstanding | 94,451,185 shares | superseded | [clm_1C00AABCAC5F](/claim/clm_1C00AABCAC5F.md)
- 2017-06-30 to 2017-09-30 | quarterly_research_and_development | 19,899,000 United States dollar | superseded | [clm_21FA6CAFCBE3](/claim/clm_21FA6CAFCBE3.md)
- 2017-06-30 to 2017-09-30 | cash_and_equivalents | 66,086,000 United States dollar | superseded | [clm_56AC44032ECC](/claim/clm_56AC44032ECC.md)
- 2017-06-30 to 2017-09-30 | total_equity | 222,056,000 United States dollar | superseded | [clm_62E6D0020106](/claim/clm_62E6D0020106.md)
- 2017-06-30 to 2017-09-30 | quarterly_operating_income | -5,282,000 United States dollar | superseded | [clm_7C0CD77D1F65](/claim/clm_7C0CD77D1F65.md)
- 2017-06-30 to 2017-09-30 | quarterly_net_income | -6,025,000 United States dollar | superseded | [clm_A44C3688D7A1](/claim/clm_A44C3688D7A1.md)
- 2017-06-30 to 2017-09-30 | total_assets | 268,157,000 United States dollar | superseded | [clm_A6C3EB1A6E4D](/claim/clm_A6C3EB1A6E4D.md)
- 2017-06-30 to 2017-09-30 | quarterly_revenue | 56,317,000 United States dollar | superseded | [clm_E79347869C22](/claim/clm_E79347869C22.md)
- 2017-07-27 to 2017-10-27 | shares_outstanding | 96,009,084 shares | superseded | [clm_6182C21918D4](/claim/clm_6182C21918D4.md)
- 2017-09-30 to 2017-12-31 | cash_and_equivalents | 122,227,000 United States dollar | superseded | [clm_0D925435BA56](/claim/clm_0D925435BA56.md)
- 2017-09-30 to 2017-12-31 | total_equity | 368,954,000 United States dollar | superseded | [clm_40046D013409](/claim/clm_40046D013409.md)
- 2017-09-30 to 2018-03-31 | quarterly_operating_income | -11,160,000 United States dollar | superseded | [clm_9BA5B42D7F23](/claim/clm_9BA5B42D7F23.md)
- 2017-09-30 to 2018-03-31 | quarterly_revenue | 62,640,000 United States dollar | superseded | [clm_A353C6A29FC0](/claim/clm_A353C6A29FC0.md)
- 2017-09-30 to 2018-03-31 | quarterly_research_and_development | 19,876,000 United States dollar | superseded | [clm_CA3FBA761061](/claim/clm_CA3FBA761061.md)
- 2017-09-30 to 2017-12-31 | total_assets | 440,152,000 United States dollar | superseded | [clm_D747C4BF25DF](/claim/clm_D747C4BF25DF.md)
- 2017-09-30 to 2018-03-31 | quarterly_net_income | -11,516,000 United States dollar | superseded | [clm_F3A8D4447600](/claim/clm_F3A8D4447600.md)
- 2017-10-27 to 2018-01-31 | shares_outstanding | 108,441,709 shares | superseded | [clm_5ECC03F1A365](/claim/clm_5ECC03F1A365.md)
- 2017-12-31 to 2018-12-31 | net_income | -20,283,000 United States dollar | superseded | [clm_01EE48E45A27](/claim/clm_01EE48E45A27.md)
- 2017-12-31 to 2018-03-31 | total_assets | 446,930,000 United States dollar | superseded | [clm_114FCD56E394](/claim/clm_114FCD56E394.md)
- 2017-12-31 to 2020-12-31 | revenue | 255,066,000 United States dollar | superseded | [clm_5A3B363247D4](/claim/clm_5A3B363247D4.md)
- 2017-12-31 to 2018-12-31 | research_and_development | 81,926,000 United States dollar | superseded | [clm_7CC1AF1365B4](/claim/clm_7CC1AF1365B4.md)
- 2017-12-31 to 2018-12-31 | operating_income | -18,967,000 United States dollar | superseded | [clm_9A0DCFF5DC34](/claim/clm_9A0DCFF5DC34.md)
- 2017-12-31 to 2018-03-31 | total_equity | 391,062,000 United States dollar | superseded | [clm_B899B7365408](/claim/clm_B899B7365408.md)
- 2017-12-31 to 2018-03-31 | cash_and_equivalents | 126,457,000 United States dollar | superseded | [clm_D0D540CDC2E2](/claim/clm_D0D540CDC2E2.md)

## 2018

- 2018-01-31 to 2018-04-25 | shares_outstanding | 109,962,798 shares | superseded | [clm_A004E2594675](/claim/clm_A004E2594675.md)
- 2018-03-31 to 2018-06-30 | quarterly_research_and_development | 25,533,000 United States dollar | superseded | [clm_03FE59F49C19](/claim/clm_03FE59F49C19.md)
- 2018-03-31 to 2018-06-30 | total_equity | 370,011,000 United States dollar | superseded | [clm_17798D35335F](/claim/clm_17798D35335F.md)
- 2018-03-31 to 2018-06-30 | quarterly_net_income | -2,617,000 United States dollar | superseded | [clm_64124F79377A](/claim/clm_64124F79377A.md)
- 2018-03-31 to 2018-06-30 | quarterly_operating_income | -2,620,000 United States dollar | superseded | [clm_66681F4DB1A3](/claim/clm_66681F4DB1A3.md)
- 2018-03-31 to 2018-06-30 | quarterly_revenue | 76,949,000 United States dollar | superseded | [clm_6976FA605FDC](/claim/clm_6976FA605FDC.md)
- 2018-03-31 to 2018-06-30 | cash_and_equivalents | 106,827,000 United States dollar | superseded | [clm_A7E906469E67](/claim/clm_A7E906469E67.md)
- 2018-03-31 to 2018-06-30 | total_assets | 423,478,000 United States dollar | superseded | [clm_FDD4CBF002F0](/claim/clm_FDD4CBF002F0.md)
- 2018-04-25 to 2018-07-27 | shares_outstanding | 112,148,773 shares | superseded | [clm_32BB8677854A](/claim/clm_32BB8677854A.md)
- 2018-06-30 to 2018-09-30 | quarterly_net_income | -3,909,000 United States dollar | superseded | [clm_0D012AF813C8](/claim/clm_0D012AF813C8.md)
- 2018-06-30 to 2018-09-30 | cash_and_equivalents | 384,926,000 United States dollar | superseded | [clm_1AA0052F1E0C](/claim/clm_1AA0052F1E0C.md)
- 2018-06-30 to 2020-03-31 | quarterly_revenue | 74,222,000 United States dollar | superseded | [clm_501026190A38](/claim/clm_501026190A38.md)
- 2018-06-30 to 2018-09-30 | total_equity | 388,719,000 United States dollar | superseded | [clm_94EC5945ADE0](/claim/clm_94EC5945ADE0.md)
- 2018-06-30 to 2018-09-30 | quarterly_research_and_development | 26,218,000 United States dollar | superseded | [clm_F5E807BEBCCE](/claim/clm_F5E807BEBCCE.md)
- 2018-06-30 to 2018-09-30 | total_assets | 720,571,000 United States dollar | superseded | [clm_FCCC811BFAD4](/claim/clm_FCCC811BFAD4.md)
- 2018-06-30 to 2018-09-30 | quarterly_operating_income | -711,000 United States dollar | superseded | [clm_FE4AAB002800](/claim/clm_FE4AAB002800.md)
- 2018-07-27 to 2018-10-26 | shares_outstanding | 113,960,276 shares | superseded | [clm_109E90CA0EC9](/claim/clm_109E90CA0EC9.md)
- 2018-09-30 to 2019-03-31 | quarterly_research_and_development | 29,045,000 United States dollar | superseded | [clm_1E65505DE333](/claim/clm_1E65505DE333.md)
- 2018-09-30 to 2019-03-31 | quarterly_operating_income | -10,433,000 United States dollar | superseded | [clm_2B646D103E71](/claim/clm_2B646D103E71.md)
- 2018-09-30 to 2018-12-31 | cash_and_equivalents | 379,020,000 United States dollar | superseded | [clm_6D7D42C29D22](/claim/clm_6D7D42C29D22.md)
- 2018-09-30 to 2019-03-31 | quarterly_net_income | -13,709,000 United States dollar | superseded | [clm_6ED5F4DFA3A8](/claim/clm_6ED5F4DFA3A8.md)
- 2018-09-30 to 2018-12-31 | total_equity | 388,581,000 United States dollar | superseded | [clm_7FE66ACBF165](/claim/clm_7FE66ACBF165.md)
- 2018-09-30 to 2018-12-31 | total_assets | 752,292,000 United States dollar | superseded | [clm_D4B1CBE602B9](/claim/clm_D4B1CBE602B9.md)
- 2018-10-26 to 2019-01-31 | shares_outstanding | 114,897,566 shares | superseded | [clm_828A4E8B72F5](/claim/clm_828A4E8B72F5.md)
- 2018-12-31 to 2019-03-31 | total_assets | 760,938,000 United States dollar | superseded | [clm_0941C3E469FE](/claim/clm_0941C3E469FE.md)
- 2018-12-31 to 2019-12-31 | operating_income | -6,220,000 United States dollar | superseded | [clm_12BC486416A2](/claim/clm_12BC486416A2.md)
- 2018-12-31 to 2019-03-31 | total_equity | 410,634,000 United States dollar | superseded | [clm_65C5327A6FED](/claim/clm_65C5327A6FED.md)
- 2018-12-31 to 2019-12-31 | net_income | -14,888,000 United States dollar | superseded | [clm_AAC41F0F4504](/claim/clm_AAC41F0F4504.md)
- 2018-12-31 to 2019-03-31 | cash_and_equivalents | 374,664,000 United States dollar | superseded | [clm_B14E2E83442C](/claim/clm_B14E2E83442C.md)
- 2018-12-31 to 2019-12-31 | research_and_development | 114,291,000 United States dollar | superseded | [clm_CE2CF6702691](/claim/clm_CE2CF6702691.md)

## 2019

- 2019-01-31 to 2019-04-26 | shares_outstanding | 115,871,582 shares | superseded | [clm_15E553FFCCB9](/claim/clm_15E553FFCCB9.md)
- 2019-03-31 to 2019-06-30 | total_equity | 428,137,000 United States dollar | superseded | [clm_36F2A73644A3](/claim/clm_36F2A73644A3.md)
- 2019-03-31 to 2019-06-30 | quarterly_operating_income | -1,027,000 United States dollar | superseded | [clm_5E4ABB047D76](/claim/clm_5E4ABB047D76.md)
- 2019-03-31 to 2019-06-30 | total_assets | 1,309,215,000 United States dollar | superseded | [clm_7C2C9D6846C5](/claim/clm_7C2C9D6846C5.md)
- 2019-03-31 to 2019-06-30 | quarterly_net_income | -4,318,000 United States dollar | superseded | [clm_94098AAA5539](/claim/clm_94098AAA5539.md)
- 2019-03-31 to 2019-06-30 | quarterly_research_and_development | 32,692,000 United States dollar | superseded | [clm_B17CBFD62CFB](/claim/clm_B17CBFD62CFB.md)
- 2019-03-31 to 2019-06-30 | cash_and_equivalents | 914,500,000 United States dollar | superseded | [clm_E05EF7F0C1D9](/claim/clm_E05EF7F0C1D9.md)
- 2019-04-26 to 2019-07-26 | shares_outstanding | 118,548,013 shares | superseded | [clm_A06094438DF2](/claim/clm_A06094438DF2.md)
- 2019-06-30 to 2019-09-30 | quarterly_research_and_development | 32,065,000 United States dollar | superseded | [clm_0681E7564BD7](/claim/clm_0681E7564BD7.md)
- 2019-06-30 to 2019-09-30 | total_equity | 459,571,000 United States dollar | superseded | [clm_297B1B6444B5](/claim/clm_297B1B6444B5.md)
- 2019-06-30 to 2019-09-30 | total_assets | 1,415,683,000 United States dollar | superseded | [clm_3C4D38701526](/claim/clm_3C4D38701526.md)
- 2019-06-30 to 2019-09-30 | quarterly_net_income | -2,029,000 United States dollar | superseded | [clm_59C419E0160D](/claim/clm_59C419E0160D.md)
- 2019-06-30 to 2019-09-30 | quarterly_operating_income | 6,815,000 United States dollar | superseded | [clm_ABB7C88B02A9](/claim/clm_ABB7C88B02A9.md)
- 2019-06-30 to 2019-09-30 | cash_and_equivalents | 555,792,000 United States dollar | superseded | [clm_D08009D3FB7C](/claim/clm_D08009D3FB7C.md)
- 2019-07-26 to 2019-11-01 | shares_outstanding | 119,651,393 shares | superseded | [clm_063BAA1DF706](/claim/clm_063BAA1DF706.md)
- 2019-09-30 to 2020-03-31 | quarterly_net_income | -11,477,000 United States dollar | superseded | [clm_2FD83578FD7C](/claim/clm_2FD83578FD7C.md)
- 2019-09-30 to 2019-12-31 | total_assets | 1,463,692,000 United States dollar | superseded | [clm_38C6E6AC729D](/claim/clm_38C6E6AC729D.md)
- 2019-09-30 to 2019-12-31 | cash_and_equivalents | 450,457,000 United States dollar | superseded | [clm_6FC64CFE261A](/claim/clm_6FC64CFE261A.md)
- 2019-09-30 to 2020-03-31 | quarterly_research_and_development | 36,442,000 United States dollar | superseded | [clm_8AEF7D20597A](/claim/clm_8AEF7D20597A.md)
- 2019-09-30 to 2020-03-31 | quarterly_operating_income | -5,057,000 United States dollar | superseded | [clm_964C81D01A8D](/claim/clm_964C81D01A8D.md)
- 2019-09-30 to 2019-12-31 | total_equity | 468,512,000 United States dollar | superseded | [clm_D561BAC1EC10](/claim/clm_D561BAC1EC10.md)
- 2019-11-01 to 2020-01-31 | shares_outstanding | 120,981,819 shares | superseded | [clm_F0E5EDE4877D](/claim/clm_F0E5EDE4877D.md)
- 2019-12-31 to 2020-12-31 | operating_income | 17,817,000 United States dollar | superseded | [clm_2BB90F951D7B](/claim/clm_2BB90F951D7B.md)
- 2019-12-31 to 2020-03-31 | cash_and_equivalents | 387,520,000 United States dollar | superseded | [clm_3C565D39AD99](/claim/clm_3C565D39AD99.md)
- 2019-12-31 to 2020-03-31 | total_equity | 498,829,000 United States dollar | superseded | [clm_5DEFCE03B617](/claim/clm_5DEFCE03B617.md)
- 2019-12-31 to 2020-12-31 | research_and_development | 139,772,000 United States dollar | superseded | [clm_8841A159E890](/claim/clm_8841A159E890.md)
- 2019-12-31 to 2020-12-31 | net_income | -9,605,000 United States dollar | superseded | [clm_A59657CF6131](/claim/clm_A59657CF6131.md)
- 2019-12-31 to 2020-03-31 | total_assets | 1,488,998,000 United States dollar | superseded | [clm_E13327C5C793](/claim/clm_E13327C5C793.md)

## 2020

- 2020-01-31 to 2020-05-01 | shares_outstanding | 121,890,028 shares | superseded | [clm_4DEA222BE3E3](/claim/clm_4DEA222BE3E3.md)
- 2020-03-31 to 2020-06-30 | quarterly_research_and_development | 39,541,000 United States dollar | superseded | [clm_00A3B399D6AF](/claim/clm_00A3B399D6AF.md)
- 2020-03-31 to 2020-06-30 | quarterly_net_income | -5,713,000 United States dollar | superseded | [clm_05F34499237D](/claim/clm_05F34499237D.md)
- 2020-03-31 to 2020-06-30 | total_assets | 1,495,004,000 United States dollar | superseded | [clm_0A38CD3570A5](/claim/clm_0A38CD3570A5.md)
- 2020-03-31 to 2020-06-30 | quarterly_revenue | 131,590,000 United States dollar | superseded | [clm_199506CFD9B3](/claim/clm_199506CFD9B3.md)
- 2020-03-31 to 2020-06-30 | total_equity | 462,927,000 United States dollar | superseded | [clm_668D599F1445](/claim/clm_668D599F1445.md)
- 2020-03-31 to 2020-06-30 | cash_and_equivalents | 359,101,000 United States dollar | superseded | [clm_AFC1989848AC](/claim/clm_AFC1989848AC.md)
- 2020-03-31 to 2020-06-30 | quarterly_operating_income | 3,276,000 United States dollar | superseded | [clm_C750A20FF06B](/claim/clm_C750A20FF06B.md)
- 2020-05-01 to 2020-07-31 | shares_outstanding | 123,646,480 shares | superseded | [clm_7C52FBA4ECE7](/claim/clm_7C52FBA4ECE7.md)
- 2020-06-30 to 2020-09-30 | quarterly_research_and_development | 40,374,000 United States dollar | superseded | [clm_2AB84766055C](/claim/clm_2AB84766055C.md)
- 2020-06-30 to 2020-09-30 | total_assets | 1,539,878,000 United States dollar | superseded | [clm_3E677ADA4F33](/claim/clm_3E677ADA4F33.md)
- 2020-06-30 to 2020-09-30 | quarterly_net_income | 10,589,000 United States dollar | superseded | [clm_52D212B4508E](/claim/clm_52D212B4508E.md)
- 2020-06-30 to 2020-09-30 | cash_and_equivalents | 285,064,000 United States dollar | superseded | [clm_76C5999A8F31](/claim/clm_76C5999A8F31.md)
- 2020-06-30 to 2020-09-30 | quarterly_revenue | 153,009,000 United States dollar | superseded | [clm_87E99795B2C6](/claim/clm_87E99795B2C6.md)
- 2020-06-30 to 2020-09-30 | total_equity | 498,378,000 United States dollar | superseded | [clm_BFFEA7D560F1](/claim/clm_BFFEA7D560F1.md)
- 2020-06-30 to 2020-09-30 | quarterly_operating_income | 22,061,000 United States dollar | superseded | [clm_EAD3F7B6C372](/claim/clm_EAD3F7B6C372.md)
- 2020-07-31 to 2020-10-23 | shares_outstanding | 124,314,241 shares | superseded | [clm_FD8DFEB245E0](/claim/clm_FD8DFEB245E0.md)
- 2020-09-30 to 2021-03-31 | quarterly_net_income | -37,140,000 United States dollar | superseded | [clm_0756D6D35E2B](/claim/clm_0756D6D35E2B.md)
- 2020-09-30 to 2021-03-31 | quarterly_revenue | 154,018,000 United States dollar | superseded | [clm_0D8107B79C44](/claim/clm_0D8107B79C44.md)
- 2020-09-30 to 2021-03-31 | quarterly_research_and_development | 44,041,000 United States dollar | superseded | [clm_21EDD655FE0B](/claim/clm_21EDD655FE0B.md)
- 2020-09-30 to 2021-03-31 | quarterly_operating_income | -17,802,000 United States dollar | superseded | [clm_41D94D858119](/claim/clm_41D94D858119.md)
- 2020-09-30 to 2020-12-31 | total_assets | 2,341,657,000 United States dollar | superseded | [clm_4DCF0AB77A6E](/claim/clm_4DCF0AB77A6E.md)
- 2020-09-30 to 2020-12-31 | total_equity | 645,392,000 United States dollar | superseded | [clm_A9AB33E40341](/claim/clm_A9AB33E40341.md)
- 2020-09-30 to 2020-12-31 | cash_and_equivalents | 527,541,000 United States dollar | superseded | [clm_D7FB476271EB](/claim/clm_D7FB476271EB.md)
- 2020-10-23 to 2021-01-31 | shares_outstanding | 128,810,888 shares | superseded | [clm_9B2F2472139D](/claim/clm_9B2F2472139D.md)
- 2020-12-31 to 2021-03-31 | total_assets | 2,251,258,000 United States dollar | superseded | [clm_085B1340F873](/claim/clm_085B1340F873.md)
- 2020-12-31 to 2021-12-31 | research_and_development | 170,905,000 United States dollar | superseded | [clm_09A8527BE491](/claim/clm_09A8527BE491.md)
- 2020-12-31 to 2021-12-31 | net_income | -6,221,000 United States dollar | superseded | [clm_1B7FFDA54E69](/claim/clm_1B7FFDA54E69.md)
- 2020-12-31 to 2021-03-31 | total_equity | 609,635,000 United States dollar | superseded | [clm_598FA737D17F](/claim/clm_598FA737D17F.md)
- 2020-12-31 to 2021-03-31 | cash_and_equivalents | 479,853,000 United States dollar | superseded | [clm_BAD00B2DC59B](/claim/clm_BAD00B2DC59B.md)
- 2020-12-31 to 2021-12-31 | operating_income | 56,753,000 United States dollar | superseded | [clm_DFA16F22A8D0](/claim/clm_DFA16F22A8D0.md)
- 2020-12-31 to 2021-12-31 | revenue | 644,338,000 United States dollar | superseded | [clm_FDDABB7D4516](/claim/clm_FDDABB7D4516.md)

## 2021

- 2021-01-31 to 2021-04-30 | shares_outstanding | 129,423,416 shares | superseded | [clm_C5CD3A91CFB8](/claim/clm_C5CD3A91CFB8.md)
- 2021-03-31 to 2021-06-30 | quarterly_net_income | -65,179,000 United States dollar | superseded | [clm_3AF1328C8BA0](/claim/clm_3AF1328C8BA0.md)
- 2021-03-31 to 2021-06-30 | cash_and_equivalents | 656,168,000 United States dollar | superseded | [clm_587E6945A1D6](/claim/clm_587E6945A1D6.md)
- 2021-03-31 to 2021-06-30 | quarterly_operating_income | 16,779,000 United States dollar | superseded | [clm_6A64EB202FCF](/claim/clm_6A64EB202FCF.md)
- 2021-03-31 to 2021-06-30 | quarterly_revenue | 198,378,000 United States dollar | superseded | [clm_7CC7461523A6](/claim/clm_7CC7461523A6.md)
- 2021-03-31 to 2021-06-30 | total_assets | 3,193,561,000 United States dollar | superseded | [clm_BF4C0C49BB7C](/claim/clm_BF4C0C49BB7C.md)
- 2021-03-31 to 2021-06-30 | total_equity | 1,243,343,000 United States dollar | superseded | [clm_BFAB227B1D58](/claim/clm_BFAB227B1D58.md)
- 2021-03-31 to 2021-06-30 | quarterly_research_and_development | 46,131,000 United States dollar | superseded | [clm_CA1E6D527E0A](/claim/clm_CA1E6D527E0A.md)
- 2021-04-30 to 2021-08-06 | shares_outstanding | 141,935,085 shares | superseded | [clm_B61E68BFBF18](/claim/clm_B61E68BFBF18.md)
- 2021-06-30 to 2021-09-30 | quarterly_revenue | 198,478,000 United States dollar | superseded | [clm_2E129CFCA242](/claim/clm_2E129CFCA242.md)
- 2021-06-30 to 2021-09-30 | total_equity | 1,337,882,000 United States dollar | superseded | [clm_40FBE1B34058](/claim/clm_40FBE1B34058.md)
- 2021-06-30 to 2021-09-30 | quarterly_operating_income | 34,770,000 United States dollar | superseded | [clm_486FF898369C](/claim/clm_486FF898369C.md)
- 2021-06-30 to 2021-09-30 | quarterly_research_and_development | 41,595,000 United States dollar | superseded | [clm_694680AAB575](/claim/clm_694680AAB575.md)
- 2021-06-30 to 2021-09-30 | cash_and_equivalents | 840,056,000 United States dollar | superseded | [clm_743542366808](/claim/clm_743542366808.md)
- 2021-06-30 to 2021-09-30 | total_assets | 3,150,947,000 United States dollar | superseded | [clm_7E968B4BA879](/claim/clm_7E968B4BA879.md)
- 2021-06-30 to 2021-09-30 | quarterly_net_income | 32,764,000 United States dollar | superseded | [clm_DE8AC57C5F6D](/claim/clm_DE8AC57C5F6D.md)
- 2021-08-06 to 2021-10-25 | shares_outstanding | 144,677,794 shares | superseded | [clm_2E8E5B731A13](/claim/clm_2E8E5B731A13.md)
- 2021-09-30 to 2022-03-31 | quarterly_operating_income | 361,000 United States dollar | superseded | [clm_3F86BC371FAB](/claim/clm_3F86BC371FAB.md)
- 2021-09-30 to 2022-03-31 | quarterly_net_income | 6,651,000 United States dollar | superseded | [clm_653A8AEF7CCE](/claim/clm_653A8AEF7CCE.md)
- 2021-09-30 to 2021-12-31 | total_assets | 3,187,495,000 United States dollar | superseded | [clm_7C9B6DC9F065](/claim/clm_7C9B6DC9F065.md)
- 2021-09-30 to 2022-03-31 | quarterly_revenue | 171,942,000 United States dollar | superseded | [clm_80E94719C759](/claim/clm_80E94719C759.md)
- 2021-09-30 to 2021-12-31 | cash_and_equivalents | 713,837,000 United States dollar | superseded | [clm_9EB9F0A0B608](/claim/clm_9EB9F0A0B608.md)
- 2021-09-30 to 2022-03-31 | quarterly_research_and_development | 43,269,000 United States dollar | superseded | [clm_D6BDE97C4786](/claim/clm_D6BDE97C4786.md)
- 2021-09-30 to 2021-12-31 | total_equity | 1,354,517,000 United States dollar | superseded | [clm_F7AF0C3DE1DB](/claim/clm_F7AF0C3DE1DB.md)
- 2021-10-25 to 2022-01-31 | shares_outstanding | 144,947,411 shares | superseded | [clm_B8F1400618A0](/claim/clm_B8F1400618A0.md)
- 2021-11-29 | owner_of | Busuu | unverified | [clm_007ABAD280A7](/claim/clm_007ABAD280A7.md)
- 2021-12-31 to 2022-03-31 | cash_and_equivalents | 854,078,000 United States dollar | superseded | [clm_0647E8F0362C](/claim/clm_0647E8F0362C.md)
- 2021-12-31 to 2022-03-31 | total_equity | 1,106,917,000 United States dollar | superseded | [clm_53CA77B5D6D5](/claim/clm_53CA77B5D6D5.md)
- 2021-12-31 to 2022-12-31 | revenue | 776,265,000 United States dollar | superseded | [clm_74E4669C1EFB](/claim/clm_74E4669C1EFB.md)
- 2021-12-31 to 2022-03-31 | total_assets | 2,919,246,000 United States dollar | superseded | [clm_8120765BF10E](/claim/clm_8120765BF10E.md)
- 2021-12-31 to 2022-12-31 | operating_income | 78,107,000 United States dollar | superseded | [clm_8D317EDF6A9F](/claim/clm_8D317EDF6A9F.md)
- 2021-12-31 to 2022-12-31 | research_and_development | 178,821,000 United States dollar | superseded | [clm_B1E7B39C2788](/claim/clm_B1E7B39C2788.md)
- 2021-12-31 to 2022-12-31 | net_income | -1,458,000 United States dollar | superseded | [clm_B6363F4451CE](/claim/clm_B6363F4451CE.md)

## 2022

- 2022-01-31 to 2022-04-25 | shares_outstanding | 134,848,498 shares | superseded | [clm_D0FEA2806DF8](/claim/clm_D0FEA2806DF8.md)
- 2022-03-31 to 2022-06-30 | total_assets | 2,662,470,000 United States dollar | superseded | [clm_081460F396DB](/claim/clm_081460F396DB.md)
- 2022-03-31 to 2022-06-30 | quarterly_operating_income | 5,376,000 United States dollar | superseded | [clm_2C7BB6E38A50](/claim/clm_2C7BB6E38A50.md)
- 2022-03-31 to 2022-06-30 | quarterly_net_income | 5,742,000 United States dollar | superseded | [clm_3C1247718642](/claim/clm_3C1247718642.md)
- 2022-03-31 to 2022-06-30 | cash_and_equivalents | 267,731,000 United States dollar | superseded | [clm_748EA41770D5](/claim/clm_748EA41770D5.md)
- 2022-03-31 to 2022-06-30 | total_equity | 808,521,000 United States dollar | superseded | [clm_97796321E6C5](/claim/clm_97796321E6C5.md)
- 2022-03-31 to 2022-06-30 | quarterly_revenue | 202,244,000 United States dollar | superseded | [clm_AC916005A323](/claim/clm_AC916005A323.md)
- 2022-03-31 to 2022-06-30 | quarterly_research_and_development | 52,415,000 United States dollar | superseded | [clm_FFA606126390](/claim/clm_FFA606126390.md)
- 2022-04-25 to 2022-07-28 | shares_outstanding | 125,894,774 shares | superseded | [clm_D2BC27FF061A](/claim/clm_D2BC27FF061A.md)
- 2022-06-30 to 2022-09-30 | quarterly_research_and_development | 52,480,000 United States dollar | superseded | [clm_08F21333487F](/claim/clm_08F21333487F.md)
- 2022-06-30 to 2022-09-30 | total_assets | 2,654,519,000 United States dollar | superseded | [clm_0A0E39AF764D](/claim/clm_0A0E39AF764D.md)
- 2022-06-30 to 2022-09-30 | quarterly_revenue | 194,721,000 United States dollar | superseded | [clm_4BFF37805443](/claim/clm_4BFF37805443.md)
- 2022-06-30 to 2022-09-30 | quarterly_net_income | 7,476,000 United States dollar | superseded | [clm_7E9F323B8A14](/claim/clm_7E9F323B8A14.md)
- 2022-06-30 to 2022-09-30 | total_equity | 818,791,000 United States dollar | superseded | [clm_94AABB638BB9](/claim/clm_94AABB638BB9.md)
- 2022-06-30 to 2022-09-30 | quarterly_operating_income | 7,343,000 United States dollar | superseded | [clm_C85B29137AD4](/claim/clm_C85B29137AD4.md)
- 2022-06-30 to 2022-09-30 | cash_and_equivalents | 402,089,000 United States dollar | superseded | [clm_FE12B38FC2E5](/claim/clm_FE12B38FC2E5.md)
- 2022-07-28 to 2022-10-25 | shares_outstanding | 126,398,679 shares | superseded | [clm_C4443AE66571](/claim/clm_C4443AE66571.md)
- 2022-09-30 to 2022-12-31 | total_assets | 2,397,861,000 United States dollar | superseded | [clm_1053720EA73C](/claim/clm_1053720EA73C.md)
- 2022-09-30 to 2022-12-31 | total_equity | 1,046,532,000 United States dollar | superseded | [clm_34B5FF911F72](/claim/clm_34B5FF911F72.md)
- 2022-09-30 to 2022-12-31 | cash_and_equivalents | 69,349,000 United States dollar | superseded | [clm_53ED7F435122](/claim/clm_53ED7F435122.md)
- 2022-09-30 to 2023-03-31 | quarterly_research_and_development | 45,426,000 United States dollar | superseded | [clm_57A3A57BA216](/claim/clm_57A3A57BA216.md)
- 2022-09-30 to 2023-03-31 | quarterly_revenue | 164,739,000 United States dollar | superseded | [clm_8D600F1FE5D5](/claim/clm_8D600F1FE5D5.md)
- 2022-09-30 to 2023-03-31 | quarterly_net_income | 251,562,000 United States dollar | superseded | [clm_CEC64BAF4074](/claim/clm_CEC64BAF4074.md)
- 2022-09-30 to 2023-03-31 | quarterly_operating_income | -11,435,000 United States dollar | superseded | [clm_F7C184B81DDC](/claim/clm_F7C184B81DDC.md)
- 2022-10-25 to 2023-01-31 | shares_outstanding | 125,477,315 shares | superseded | [clm_54EACC8DEBDD](/claim/clm_54EACC8DEBDD.md)
- 2022-12-31 to 2023-12-31 | research_and_development | 196,637,000 United States dollar | superseded | [clm_104E38AFFB28](/claim/clm_104E38AFFB28.md)
- 2022-12-31 to 2023-12-31 | operating_income | 8,957,000 United States dollar | superseded | [clm_1D6EB9F1A332](/claim/clm_1D6EB9F1A332.md)
- 2022-12-31 to 2023-12-31 | net_income | 266,638,000 United States dollar | superseded | [clm_2E5C985FFA98](/claim/clm_2E5C985FFA98.md)
- 2022-12-31 to 2023-03-31 | total_equity | 1,116,589,000 United States dollar | superseded | [clm_75F7FD04AB4D](/claim/clm_75F7FD04AB4D.md)
- 2022-12-31 to 2023-03-31 | cash_and_equivalents | 473,677,000 United States dollar | superseded | [clm_A8448C57D9C2](/claim/clm_A8448C57D9C2.md)
- 2022-12-31 to 2023-03-31 | total_assets | 2,465,416,000 United States dollar | superseded | [clm_DECC12C388F1](/claim/clm_DECC12C388F1.md)
- 2022-12-31 to 2023-12-31 | revenue | 766,897,000 United States dollar | superseded | [clm_EC376DCB2968](/claim/clm_EC376DCB2968.md)

## 2023

- 2023-01-31 to 2023-04-24 | shares_outstanding | 126,551,885 shares | superseded | [clm_618CBDDCA60C](/claim/clm_618CBDDCA60C.md)
- 2023-03-31 to 2023-06-30 | quarterly_revenue | 187,601,000 United States dollar | superseded | [clm_34716707053A](/claim/clm_34716707053A.md)
- 2023-03-31 to 2023-06-30 | quarterly_operating_income | -4,446,000 United States dollar | superseded | [clm_3FFE4CA4F0B3](/claim/clm_3FFE4CA4F0B3.md)
- 2023-03-31 to 2023-06-30 | total_assets | 2,361,787,000 United States dollar | superseded | [clm_7F7E726B2BC3](/claim/clm_7F7E726B2BC3.md)
- 2023-03-31 to 2023-06-30 | quarterly_research_and_development | 46,907,000 United States dollar | superseded | [clm_B42E80375822](/claim/clm_B42E80375822.md)
- 2023-03-31 to 2023-06-30 | quarterly_net_income | 2,186,000 United States dollar | superseded | [clm_C5E8B105A328](/claim/clm_C5E8B105A328.md)
- 2023-03-31 to 2023-06-30 | total_equity | 1,006,759,000 United States dollar | superseded | [clm_E2355CBF4E3C](/claim/clm_E2355CBF4E3C.md)
- 2023-03-31 to 2023-06-30 | cash_and_equivalents | 281,302,000 United States dollar | superseded | [clm_F5B98B554E96](/claim/clm_F5B98B554E96.md)
- 2023-04-24 to 2023-07-31 | shares_outstanding | 119,716,256 shares | superseded | [clm_E67F9EA51B06](/claim/clm_E67F9EA51B06.md)
- 2023-06-30 to 2023-09-30 | total_equity | 1,035,001,000 United States dollar | superseded | [clm_1D954A310241](/claim/clm_1D954A310241.md)
- 2023-06-30 to 2023-09-30 | quarterly_net_income | 24,612,000 United States dollar | superseded | [clm_2A88B18E1738](/claim/clm_2A88B18E1738.md)
- 2023-06-30 to 2023-09-30 | quarterly_revenue | 182,853,000 United States dollar | superseded | [clm_8AAD5964AC90](/claim/clm_8AAD5964AC90.md)
- 2023-06-30 to 2023-09-30 | cash_and_equivalents | 175,368,000 United States dollar | superseded | [clm_9853FA185C38](/claim/clm_9853FA185C38.md)
- 2023-06-30 to 2023-09-30 | quarterly_research_and_development | 52,872,000 United States dollar | superseded | [clm_9DE040A82198](/claim/clm_9DE040A82198.md)
- 2023-06-30 to 2023-09-30 | total_assets | 1,968,535,000 United States dollar | superseded | [clm_ACF8CC80C1D0](/claim/clm_ACF8CC80C1D0.md)
- 2023-06-30 to 2023-09-30 | quarterly_operating_income | -18,696,000 United States dollar | superseded | [clm_B2A378102869](/claim/clm_B2A378102869.md)
- 2023-07-31 to 2023-10-23 | shares_outstanding | 115,321,288 shares | superseded | [clm_5769B29FC1E0](/claim/clm_5769B29FC1E0.md)
- 2023-09-30 to 2023-12-31 | total_assets | 1,804,639,000 United States dollar | superseded | [clm_538D7135D2B3](/claim/clm_538D7135D2B3.md)
- 2023-09-30 to 2024-03-31 | quarterly_revenue | 157,854,000 United States dollar | superseded | [clm_6D0CE9AB5ACC](/claim/clm_6D0CE9AB5ACC.md)
- 2023-09-30 to 2024-03-31 | quarterly_operating_income | -57,870,000 United States dollar | superseded | [clm_9053BFCF8C2F](/claim/clm_9053BFCF8C2F.md)
- 2023-09-30 to 2023-12-31 | cash_and_equivalents | 94,419,000 United States dollar | superseded | [clm_9BB8E3E1FE4D](/claim/clm_9BB8E3E1FE4D.md)
- 2023-09-30 to 2024-03-31 | quarterly_net_income | -18,283,000 United States dollar | superseded | [clm_C9E16AB0A986](/claim/clm_C9E16AB0A986.md)
- 2023-09-30 to 2023-12-31 | total_equity | 1,033,349,000 United States dollar | superseded | [clm_F804F6B5D127](/claim/clm_F804F6B5D127.md)
- 2023-09-30 to 2024-03-31 | quarterly_research_and_development | 46,202,000 United States dollar | superseded | [clm_FBBD1B41CDE3](/claim/clm_FBBD1B41CDE3.md)
- 2023-10-23 to 2024-01-31 | shares_outstanding | 115,814,932 shares | superseded | [clm_8BF0B87ECDA9](/claim/clm_8BF0B87ECDA9.md)
- 2023-12-31 to 2024-03-31 | cash_and_equivalents | 135,757,000 United States dollar | superseded | [clm_1AB1BB847B2A](/claim/clm_1AB1BB847B2A.md)
- 2023-12-31 to 2024-12-31 | revenue | 716,295,000 United States dollar | superseded | [clm_74551F81A40D](/claim/clm_74551F81A40D.md)
- 2023-12-31 to 2024-12-31 | research_and_development | 191,705,000 United States dollar | superseded | [clm_8616D5698B18](/claim/clm_8616D5698B18.md)
- 2023-12-31 to 2024-03-31 | total_assets | 1,727,235,000 United States dollar | superseded | [clm_C0461BABD2AB](/claim/clm_C0461BABD2AB.md)
- 2023-12-31 to 2024-03-31 | total_equity | 944,618,000 United States dollar | superseded | [clm_DAD2FF3D1C3A](/claim/clm_DAD2FF3D1C3A.md)
- 2023-12-31 to 2024-12-31 | operating_income | -67,725,000 United States dollar | superseded | [clm_F12AA3453851](/claim/clm_F12AA3453851.md)
- 2023-12-31 to 2024-12-31 | net_income | 18,180,000 United States dollar | superseded | [clm_FA50ABE3887E](/claim/clm_FA50ABE3887E.md)

## 2024

- 2024-01-31 to 2024-04-22 | shares_outstanding | 102,949,023 shares | superseded | [clm_5DC767D57D73](/claim/clm_5DC767D57D73.md)
- 2024-02-21 | cfo | David Longo | valid | [clm_0B45DD5D9DDB](/claim/clm_0B45DD5D9DDB.md)
- 2024-03-31 to 2024-06-30 | total_equity | 963,474,000 United States dollar | superseded | [clm_2743CA02A762](/claim/clm_2743CA02A762.md)
- 2024-03-31 to 2024-06-30 | quarterly_net_income | -1,420,000 United States dollar | superseded | [clm_3EBBF7D341C4](/claim/clm_3EBBF7D341C4.md)
- 2024-03-31 to 2024-06-30 | quarterly_research_and_development | 44,435,000 United States dollar | superseded | [clm_5529532BB646](/claim/clm_5529532BB646.md)
- 2024-03-31 to 2024-06-30 | quarterly_operating_income | -2,491,000 United States dollar | superseded | [clm_7DB582253BA6](/claim/clm_7DB582253BA6.md)
- 2024-03-31 to 2024-06-30 | cash_and_equivalents | 143,747,000 United States dollar | superseded | [clm_D3D53AA52D3A](/claim/clm_D3D53AA52D3A.md)
- 2024-03-31 to 2024-06-30 | quarterly_revenue | 174,350,000 United States dollar | superseded | [clm_DA20C89766C1](/claim/clm_DA20C89766C1.md)
- 2024-03-31 to 2024-06-30 | total_assets | 1,732,644,000 United States dollar | superseded | [clm_E4E4F2FEF3BB](/claim/clm_E4E4F2FEF3BB.md)
- 2024-04-22 to 2024-07-29 | shares_outstanding | 102,217,351 shares | superseded | [clm_39161FF01443](/claim/clm_39161FF01443.md)
- 2024-06-01 | board_member | Nathan Schultz | valid | [clm_05334276CCB1](/claim/clm_05334276CCB1.md)
- 2024-06-01 | ceo | Nathan Schultz | valid | [clm_4636A489FCE3](/claim/clm_4636A489FCE3.md)
- 2024-06-30 to 2024-09-30 | total_equity | 365,500,000 United States dollar | superseded | [clm_000917A7EB6D](/claim/clm_000917A7EB6D.md)
- 2024-06-30 to 2024-09-30 | quarterly_operating_income | -485,007,000 United States dollar | superseded | [clm_40907F47F399](/claim/clm_40907F47F399.md)
- 2024-06-30 to 2024-09-30 | quarterly_research_and_development | 43,651,000 United States dollar | superseded | [clm_4D56FD041999](/claim/clm_4D56FD041999.md)
- 2024-06-30 to 2024-09-30 | quarterly_revenue | 163,147,000 United States dollar | superseded | [clm_B7B14E39F840](/claim/clm_B7B14E39F840.md)
- 2024-06-30 to 2024-09-30 | total_assets | 1,114,330,000 United States dollar | superseded | [clm_D08C2EBE00D0](/claim/clm_D08C2EBE00D0.md)
- 2024-06-30 to 2024-09-30 | cash_and_equivalents | 133,068,000 United States dollar | superseded | [clm_DB2057A7DCAA](/claim/clm_DB2057A7DCAA.md)
- 2024-06-30 to 2024-09-30 | quarterly_net_income | -616,884,000 United States dollar | superseded | [clm_FF72FBAA7377](/claim/clm_FF72FBAA7377.md)
- 2024-07-29 to 2024-11-05 | shares_outstanding | 103,669,879 shares | superseded | [clm_583948C06E71](/claim/clm_583948C06E71.md)
- 2024-09-30 to 2025-03-31 | quarterly_research_and_development | 41,337,000 United States dollar | superseded | [clm_8C8E7B6736FE](/claim/clm_8C8E7B6736FE.md)
- 2024-09-30 to 2024-12-31 | total_equity | 184,981,000 United States dollar | superseded | [clm_A6F4A008C7B7](/claim/clm_A6F4A008C7B7.md)
- 2024-09-30 to 2024-12-31 | total_assets | 1,002,672,000 United States dollar | superseded | [clm_ABCBB85EA09F](/claim/clm_ABCBB85EA09F.md)
- 2024-09-30 to 2025-03-31 | quarterly_operating_income | -222,290,000 United States dollar | superseded | [clm_AE7106EB90BF](/claim/clm_AE7106EB90BF.md)
- 2024-09-30 to 2025-03-31 | quarterly_revenue | 136,593,000 United States dollar | superseded | [clm_B947E2C6777D](/claim/clm_B947E2C6777D.md)
- 2024-09-30 to 2025-03-31 | quarterly_net_income | -212,639,000 United States dollar | superseded | [clm_C3AA72CC206B](/claim/clm_C3AA72CC206B.md)
- 2024-09-30 to 2024-12-31 | cash_and_equivalents | 152,073,000 United States dollar | superseded | [clm_F9263E8357BB](/claim/clm_F9263E8357BB.md)
- 2024-11-05 to 2025-01-31 | shares_outstanding | 104,307,327 shares | superseded | [clm_96E63E3ADBB7](/claim/clm_96E63E3ADBB7.md)
- 2024-12-31 to 2025-12-31 | operating_income | -737,108,000 United States dollar | superseded | [clm_19EA0075DB65](/claim/clm_19EA0075DB65.md)
- 2024-12-31 to 2025-03-31 | total_assets | 868,951,000 United States dollar | superseded | [clm_293ABDCB8CC5](/claim/clm_293ABDCB8CC5.md)
- 2024-12-31 to 2025-03-31 | total_equity | 192,981,000 United States dollar | superseded | [clm_45BDAC56AE2A](/claim/clm_45BDAC56AE2A.md)
- 2024-12-31 to 2025-03-31 | cash_and_equivalents | 161,475,000 United States dollar | superseded | [clm_6AFE208FFF37](/claim/clm_6AFE208FFF37.md)
- 2024-12-31 to 2025-12-31 | net_income | -837,068,000 United States dollar | superseded | [clm_771035E608FF](/claim/clm_771035E608FF.md)
- 2024-12-31 to 2025-12-31 | research_and_development | 170,431,000 United States dollar | superseded | [clm_848AC6EA4D5E](/claim/clm_848AC6EA4D5E.md)
- 2024-12-31 to 2025-12-31 | revenue | 617,574,000 United States dollar | superseded | [clm_CC36DC6652A0](/claim/clm_CC36DC6652A0.md)

## 2025

- 2025-01-31 to 2025-05-05 | shares_outstanding | 105,109,136 shares | superseded | [clm_E1E15FDD3DBC](/claim/clm_E1E15FDD3DBC.md)
- 2025-03-31 to 2025-06-30 | total_assets | 438,769,000 United States dollar | superseded | [clm_12B7FBE01E19](/claim/clm_12B7FBE01E19.md)
- 2025-03-31 to 2025-06-30 | cash_and_equivalents | 44,105,000 United States dollar | superseded | [clm_4FA0717E5FDB](/claim/clm_4FA0717E5FDB.md)
- 2025-03-31 to 2025-06-30 | total_equity | 185,671,000 United States dollar | superseded | [clm_57365E70A538](/claim/clm_57365E70A538.md)
- 2025-03-31 to 2025-06-30 | quarterly_revenue | 121,387,000 United States dollar | superseded | [clm_5CF1B8B221CB](/claim/clm_5CF1B8B221CB.md)
- 2025-03-31 to 2025-06-30 | quarterly_operating_income | -29,002,000 United States dollar | superseded | [clm_5D2F8472F215](/claim/clm_5D2F8472F215.md)
- 2025-03-31 to 2025-06-30 | quarterly_research_and_development | 29,428,000 United States dollar | superseded | [clm_765A39B28B3A](/claim/clm_765A39B28B3A.md)
- 2025-03-31 to 2025-06-30 | quarterly_net_income | -17,484,000 United States dollar | superseded | [clm_940E603DFBF2](/claim/clm_940E603DFBF2.md)
- 2025-04-01 | delisting_notice | New York Stock Exchange | valid | [clm_93ED9D185AC6](/claim/clm_93ED9D185AC6.md)
- 2025-05-05 to 2025-08-04 | shares_outstanding | 106,570,452 shares | superseded | [clm_B4B607DA4E03](/claim/clm_B4B607DA4E03.md)
- 2025-05-12 | restructuring | Workforce reduction of 248 employees, about 22%, and operational streamlining actions | valid | [clm_1CF453E32069](/claim/clm_1CF453E32069.md)
- 2025-06-30 to 2025-09-30 | quarterly_operating_income | -36,458,000 United States dollar | superseded | [clm_63128D02EC22](/claim/clm_63128D02EC22.md)
- 2025-06-30 to 2025-09-30 | cash_and_equivalents | 36,825,000 United States dollar | superseded | [clm_724B49CB0C00](/claim/clm_724B49CB0C00.md)
- 2025-06-30 to 2025-09-30 | total_equity | 157,856,000 United States dollar | superseded | [clm_7D918E547E1C](/claim/clm_7D918E547E1C.md)
- 2025-06-30 to 2025-09-30 | quarterly_revenue | 105,120,000 United States dollar | superseded | [clm_DCFE76F2A53F](/claim/clm_DCFE76F2A53F.md)
- 2025-06-30 to 2025-09-30 | quarterly_net_income | -35,663,000 United States dollar | superseded | [clm_E978559FBE2D](/claim/clm_E978559FBE2D.md)
- 2025-06-30 to 2025-09-30 | total_assets | 404,453,000 United States dollar | superseded | [clm_ED46B013A9C2](/claim/clm_ED46B013A9C2.md)
- 2025-06-30 to 2025-09-30 | quarterly_research_and_development | 28,717,000 United States dollar | superseded | [clm_ED4A5732B14D](/claim/clm_ED4A5732B14D.md)
- 2025-08-04 to 2025-11-05 | shares_outstanding | 108,326,990 shares | superseded | [clm_D6996C7CE165](/claim/clm_D6996C7CE165.md)
- 2025-09-30 to 2025-12-31 | cash_and_equivalents | 38,180,000 United States dollar | superseded | [clm_0CE17BE76A0A](/claim/clm_0CE17BE76A0A.md)
- 2025-09-30 to 2025-12-31 | total_equity | 146,053,000 United States dollar | superseded | [clm_673F4F090FFA](/claim/clm_673F4F090FFA.md)
- 2025-09-30 to 2026-03-31 | quarterly_research_and_development | 18,350,000 United States dollar | superseded | [clm_8FBE926D88DE](/claim/clm_8FBE926D88DE.md)
- 2025-09-30 to 2026-03-31 | quarterly_net_income | -17,471,000 United States dollar | superseded | [clm_9B90BE755638](/claim/clm_9B90BE755638.md)
- 2025-09-30 to 2025-12-31 | total_assets | 378,271,000 United States dollar | superseded | [clm_B09160969E8C](/claim/clm_B09160969E8C.md)
- 2025-09-30 to 2026-03-31 | quarterly_operating_income | -17,124,000 United States dollar | superseded | [clm_CB35CD2C3D61](/claim/clm_CB35CD2C3D61.md)
- 2025-09-30 to 2026-03-31 | quarterly_revenue | 77,742,000 United States dollar | superseded | [clm_D7315DE7875F](/claim/clm_D7315DE7875F.md)
- 2025-10-27 | restructuring | Workforce reduction of about 45% and streamlining to align with standalone strategy | valid | [clm_74211CF6C140](/claim/clm_74211CF6C140.md)
- 2025-10-27 | president | Dan Rosensweig | valid | [clm_E815AA64B3F8](/claim/clm_E815AA64B3F8.md)
- 2025-11-05 to 2026-02-28 | shares_outstanding | 109,273,108 shares | superseded | [clm_2C2D5FA336E3](/claim/clm_2C2D5FA336E3.md)
- 2025-12-31 | revenue | 376,908,000 United States dollar | valid | [clm_38C1A65012E4](/claim/clm_38C1A65012E4.md)
- 2025-12-31 to 2026-03-31 | total_assets | 278,014,000 United States dollar | superseded | [clm_BCD62C3DBA14](/claim/clm_BCD62C3DBA14.md)
- 2025-12-31 to 2026-03-31 | cash_and_equivalents | 31,146,000 United States dollar | superseded | [clm_C42A11295953](/claim/clm_C42A11295953.md)
- 2025-12-31 | research_and_development | 93,453,000 United States dollar | valid | [clm_D016DC7EAB21](/claim/clm_D016DC7EAB21.md)
- 2025-12-31 to 2026-03-31 | total_equity | 119,623,000 United States dollar | superseded | [clm_D2BE5C5A277F](/claim/clm_D2BE5C5A277F.md)
- 2025-12-31 | net_income | -103,421,000 United States dollar | valid | [clm_DD51F4441B87](/claim/clm_DD51F4441B87.md)
- 2025-12-31 | operating_income | -116,856,000 United States dollar | valid | [clm_FB039E7F7BDD](/claim/clm_FB039E7F7BDD.md)

## 2026

- 2026-02-28 to 2026-05-04 | shares_outstanding | 111,798,694 shares | superseded | [clm_D758E57F7F45](/claim/clm_D758E57F7F45.md)
- 2026-03-31 to 2026-06-30 | quarterly_operating_income | -1,037,000 United States dollar | superseded | [clm_00018936166B](/claim/clm_00018936166B.md)
- 2026-03-31 to 2026-06-30 | quarterly_research_and_development | 9,139,000 United States dollar | superseded | [clm_20686BD13441](/claim/clm_20686BD13441.md)
- 2026-03-31 to 2026-06-30 | total_equity | 121,143,000 United States dollar | superseded | [clm_95311B4693C2](/claim/clm_95311B4693C2.md)
- 2026-03-31 to 2026-06-30 | cash_and_equivalents | 33,526,000 United States dollar | superseded | [clm_A5905289D23C](/claim/clm_A5905289D23C.md)
- 2026-03-31 to 2026-06-30 | total_assets | 244,102,000 United States dollar | superseded | [clm_C2D51C2B47FA](/claim/clm_C2D51C2B47FA.md)
- 2026-03-31 to 2026-06-30 | quarterly_net_income | 228,000 United States dollar | superseded | [clm_C3864DD56830](/claim/clm_C3864DD56830.md)
- 2026-03-31 to 2026-06-30 | quarterly_revenue | 63,262,000 United States dollar | superseded | [clm_E05220D54B7D](/claim/clm_E05220D54B7D.md)
- 2026-05-04 to 2026-08-03 | shares_outstanding | 111,958,838 shares | superseded | [clm_D910A599E265](/claim/clm_D910A599E265.md)
- 2026-06-30 | quarterly_revenue | 51,849,000 United States dollar | valid | [clm_29E92955FC9E](/claim/clm_29E92955FC9E.md)
- 2026-06-30 | quarterly_research_and_development | 7,398,000 United States dollar | valid | [clm_55D11F96E19B](/claim/clm_55D11F96E19B.md)
- 2026-06-30 | quarterly_operating_income | -3,175,000 United States dollar | valid | [clm_6C27DE2669AC](/claim/clm_6C27DE2669AC.md)
- 2026-06-30 | total_equity | 118,614,000 United States dollar | valid | [clm_7482D278C9BA](/claim/clm_7482D278C9BA.md)
- 2026-06-30 | cash_and_equivalents | 44,623,000 United States dollar | valid | [clm_8169B1D5F685](/claim/clm_8169B1D5F685.md)
- 2026-06-30 | quarterly_net_income | -2,951,000 United States dollar | valid | [clm_C3DBAF8B1B77](/claim/clm_C3DBAF8B1B77.md)
- 2026-06-30 | total_assets | 227,625,000 United States dollar | valid | [clm_CD3486A73988](/claim/clm_CD3486A73988.md)
- 2026-08-03 | shares_outstanding | 111,027,482 shares | valid | [clm_ACA5DC9DBA26](/claim/clm_ACA5DC9DBA26.md)
---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.